Hormone Therapy for Breast Cancer Linked with Lower Dementia Risk

Hormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer’s disease and related dementias later in life, according to a new study published in JAMA Network Open. The study, which is one of the largest of its kind, found that although HMT was linked with protection against the development of dementia overall, the association decreased with age and varied by race.

Francesmary Modugno, PhD, MPH, professor of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh and member of Magee-Womens Research Institute and UPMC Hillman Cancer Center, was senior author of the study.

View the full press release on UPMC.com.